Congress Asset Management »

iShares NASDAQ Biotechnology Index shares owned by Congress Asset Management

Quarter-by-quarter ownership of iShares NASDAQ Biotechnology Index (IBB) shares owned by Congress Asset Management from 13F filings

Historical chart of Congress Asset Management investment in iShares NASDAQ Biotechnology Index

Tip: Access up to 7 years of quarterly data

All positions including iShares NASDAQ Biotechnology Index held by Congress Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares NASDAQ Biotechnology Index by Congress Asset Management

Quarter filed Position value Share count Share price at filing
2026-09-30 $1.3M 6.2k 210.53

More positions owned by Congress Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Halozyme Therapeutics (HALO)
Arista Networks (ANET)
Ligand Pharmaceuticals In (LGND)
Facebook Inc cl a (META)
Repligen Corporation (RGEN)
Visa (V)
Amazon (AMZN)
Costco Wholesale Corporation (COST)
Amphenol Corporation (APH)
Mongodb Inc. Class A (MDB)

View all positions for Congress Asset Management

Top funds holding iShares NASDAQ Biotechnology Index

Bank of America Corporation
Bnp Paribas Arbitrage, Snc
Two Sigma Investments
Goldman Sachs Group
Envestnet Asset Management
Raymond James Financial
Wells Fargo & Company
Commerce Bank N A
UBS Group
Peak6
Susquehanna International
LPL Financial
Royal Bank of Canada
Healthcare Of Ontario Pension Plan Trust Fund
Branch Banking & Trust Company

View all funds holding iShares NASDAQ Biotechnology Index